These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 22984008)
1. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Fiorella D; Derdeyn CP; Lynn MJ; Barnwell SL; Hoh BL; Levy EI; Harrigan MR; Klucznik RP; McDougall CG; Pride GL; Zaidat OO; Lutsep HL; Waters MF; Hourihane JM; Alexandrov AV; Chiu D; Clark JM; Johnson MD; Torbey MT; Rumboldt Z; Cloft HJ; Turan TN; Lane BF; Janis LS; Chimowitz MI; Stroke; 2012 Oct; 43(10):2682-8. PubMed ID: 22984008 [TBL] [Abstract][Full Text] [Related]
2. Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis? Lutsep HL; Lynn MJ; Cotsonis GA; Derdeyn CP; Turan TN; Fiorella D; Janis LS; Lane BF; Montgomery J; Chimowitz MI; Stroke; 2015 Nov; 46(11):3282-4. PubMed ID: 26382173 [TBL] [Abstract][Full Text] [Related]
3. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study. Dumont TM; Kan P; Snyder KV; Hopkins LN; Siddiqui AH; Levy EI Neurosurgery; 2012 Dec; 71(6):1103-10. PubMed ID: 22986593 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Derdeyn CP; Fiorella D; Lynn MJ; Rumboldt Z; Cloft HJ; Gibson D; Turan TN; Lane BF; Janis LS; Chimowitz MI; Neurosurgery; 2013 May; 72(5):777-95; discussion 795. PubMed ID: 23328689 [TBL] [Abstract][Full Text] [Related]
5. Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis). Derdeyn CP; Fiorella D; Lynn MJ; Turan TN; Cotsonis GA; Lane BF; Montgomery J; Janis LS; Chimowitz MI; Stroke; 2017 Jun; 48(6):1501-1506. PubMed ID: 28455321 [TBL] [Abstract][Full Text] [Related]
6. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Derdeyn CP; Chimowitz MI; Lynn MJ; Fiorella D; Turan TN; Janis LS; Montgomery J; Nizam A; Lane BF; Lutsep HL; Barnwell SL; Waters MF; Hoh BL; Hourihane JM; Levy EI; Alexandrov AV; Harrigan MR; Chiu D; Klucznik RP; Clark JM; McDougall CG; Johnson MD; Pride GL; Lynch JR; Zaidat OO; Rumboldt Z; Cloft HJ; Lancet; 2014 Jan; 383(9914):333-41. PubMed ID: 24168957 [TBL] [Abstract][Full Text] [Related]
7. Learning curve of Wingspan stenting for intracranial atherosclerosis: single-center experience of 95 consecutive patients. Yu SC; Leung TW; Lee KT; Wong LK J Neurointerv Surg; 2014 Apr; 6(3):212-8. PubMed ID: 23516268 [TBL] [Abstract][Full Text] [Related]
8. Percutaneous transluminal angioplasty and stenting in acute stroke caused by basilar artery steno-occlusive disease: The experience of a single stroke centre. Machado M; Borges de Almeida G; Sequeira M; Pedro F; Fior A; Carvalho R; Fragata I; Reis J; Nunes AP Interv Neuroradiol; 2022 Oct; 28(5):547-555. PubMed ID: 34704502 [TBL] [Abstract][Full Text] [Related]
9. Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. Derdeyn CP; Fiorella D; Lynn MJ; Barnwell SL; Zaidat OO; Meyers PM; Gobin YP; Dion J; Lane BF; Turan TN; Janis LS; Chimowitz MI; J Neurointerv Surg; 2013 Nov; 5(6):528-33. PubMed ID: 22977278 [TBL] [Abstract][Full Text] [Related]
10. Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study. Dumont TM; Sonig A; Mokin M; Eller JL; Sorkin GC; Snyder KV; Hopkins LN; Levy EI; Siddiqui AH J Neurosurg; 2016 Oct; 125(4):964-971. PubMed ID: 26745485 [TBL] [Abstract][Full Text] [Related]
11. Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial. Waters MF; Hoh BL; Lynn MJ; Kwon HM; Turan TN; Derdeyn CP; Fiorella D; Khanna A; Sheehan TO; Lane BF; Janis S; Montgomery J; Chimowitz MI; JAMA Neurol; 2016 Mar; 73(3):308-15. PubMed ID: 26747792 [TBL] [Abstract][Full Text] [Related]
12. Multicenter Prospective Trial of Stent Placement in Patients with Symptomatic High-Grade Intracranial Stenosis. Gao P; Wang D; Zhao Z; Cai Y; Li T; Shi H; Wu W; He W; Yin L; Huang S; Zhu F; Jiao L; Ji X; Qureshi AI; Ling F AJNR Am J Neuroradiol; 2016 Jul; 37(7):1275-80. PubMed ID: 26869472 [TBL] [Abstract][Full Text] [Related]
13. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. Chimowitz MI; Lynn MJ; Turan TN; Fiorella D; Lane BF; Janis S; Derdeyn CP; J Stroke Cerebrovasc Dis; 2011; 20(4):357-68. PubMed ID: 21729789 [TBL] [Abstract][Full Text] [Related]
14. Rate of postprocedural stroke and death in SAMMPRIS trial-eligible patients treated with intracranial angioplasty and/or stent placement in practice. Siddiq F; Chaudhry SA; Khatri R; Rodriguez GJ; Tummala R; Suri MF; Qureshi AI Neurosurgery; 2012 Jul; 71(1):68-73. PubMed ID: 22382209 [TBL] [Abstract][Full Text] [Related]
15. Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial. Gao P; Wang T; Wang D; Liebeskind DS; Shi H; Li T; Zhao Z; Cai Y; Wu W; He W; Yu J; Zheng B; Wang H; Wu Y; Dmytriw AA; Krings T; Derdeyn CP; Jiao L; JAMA; 2022 Aug; 328(6):534-542. PubMed ID: 35943472 [TBL] [Abstract][Full Text] [Related]
16. Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial. Kwon HM; Lynn MJ; Turan TN; Derdeyn CP; Fiorella D; Lane BF; Montgomery J; Janis LS; Rumboldt Z; Chimowitz MI; JAMA Neurol; 2016 Jan; 73(1):36-42. PubMed ID: 26618534 [TBL] [Abstract][Full Text] [Related]
17. Technical Nuance of Sub 2-mm Middle Cerebral Artery Angioplasty and Stenting. Kumar N; Jaurra A; Khan M; Gomez CR; Qureshi AI; Siddiq F World Neurosurg; 2022 Nov; 167():55. PubMed ID: 35995354 [TBL] [Abstract][Full Text] [Related]
18. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients. Rohde S; Seckinger J; Hähnel S; Ringleb PA; Bendszus M; Hartmann M Int J Stroke; 2013 Feb; 8(2):87-94. PubMed ID: 22296983 [TBL] [Abstract][Full Text] [Related]
19. Thirty-Day Outcomes of Resolute Onyx Stent for Symptomatic Intracranial Stenosis: A Multicenter Propensity Score-Matched Comparison With Stenting Versus Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. Siddiq F; Nunna RS; Beall JM; Khan I; Khan M; Tekle WG; Ezzeldin M; Tanweer O; Burkhardt JK; Jabbour PM; Tjoumakaris SI; Herial NA; Siddiqui AH; Grandhi R; Martin RL; Qureshi AI; Hassan AE Neurosurgery; 2023 Jun; 92(6):1155-1162. PubMed ID: 36700730 [TBL] [Abstract][Full Text] [Related]
20. Remote pre-procedural ischemic stroke as the greatest risk in carotid‑stenting‑associated stroke and death: a single center's experience. Rašiová M; Špak Ľ; Farkašová Ľ; Pataky Š; Koščo M; Hudák M; Moščovič M; Leško N Int Angiol; 2017 Aug; 36(4):306-315. PubMed ID: 27905692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]